141 related articles for article (PubMed ID: 29307346)
1. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells.
de Guadalupe Chávez-López M; Hernández-Gallegos E; Vázquez-Sánchez AY; Gariglio P; Camacho J
Int J Gynecol Cancer; 2014 Jun; 24(5):824-8. PubMed ID: 24819656
[TBL] [Abstract][Full Text] [Related]
3. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
[TBL] [Abstract][Full Text] [Related]
4. Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
de Guadalupe Chávez-López M; Pérez-Carreón JI; Zuñiga-García V; Díaz-Chávez J; Herrera LA; Caro-Sánchez CH; Acuña-Macías I; Gariglio P; Hernández-Gallegos E; Chiliquinga AJ; Camacho J
Tumour Biol; 2015 Aug; 36(8):6149-58. PubMed ID: 25783527
[TBL] [Abstract][Full Text] [Related]
5. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
[TBL] [Abstract][Full Text] [Related]
6. Astemizole: an old anti-histamine as a new promising anti-cancer drug.
García-Quiroz J; Camacho J
Anticancer Agents Med Chem; 2011 Mar; 11(3):307-14. PubMed ID: 21443504
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
[TBL] [Abstract][Full Text] [Related]
8. ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS.
García-Quiroz J; González-González ME; Díaz L; Ordaz-Rosado D; Segovia-Mendoza M; Prado-García H; Larrea F; García-Becerra R
Rev Invest Clin; 2019; 71(3):186-194. PubMed ID: 31184333
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells.
Avila E; García-Becerra R; Rodríguez-Rasgado JA; Díaz L; Ordaz-Rosado D; Zügel U; Steinmeyer A; Barrera D; Halhali A; Larrea F; Camacho J
Anticancer Res; 2010 Jul; 30(7):2667-72. PubMed ID: 20682996
[TBL] [Abstract][Full Text] [Related]
10. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
[TBL] [Abstract][Full Text] [Related]
11. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
[TBL] [Abstract][Full Text] [Related]
12. The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells.
Horst CH; Titze-de-Almeida R; Titze-de-Almeida SS
Mol Med Rep; 2017 Apr; 15(4):1479-1488. PubMed ID: 28259991
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines.
Ding XW; Luo HS; Jin X; Yan JJ; Ai YW
Med Oncol; 2007; 24(3):345-50. PubMed ID: 17873312
[TBL] [Abstract][Full Text] [Related]
14. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26.
Rivette AS; Tokar EJ; Williams DE; Mackenzie CD; Ablin RJ; Webber MM
J Exp Ther Oncol; 2005; 5(2):111-23. PubMed ID: 16471037
[TBL] [Abstract][Full Text] [Related]
15. The combination astemizole-gefitinib as a potential therapy for human lung cancer.
Chávez-López MG; Zúñiga-García V; Hernández-Gallegos E; Vera E; Chasiquiza-Anchatuña CA; Viteri-Yánez M; Sanchez-Ramos J; Garrido E; Camacho J
Onco Targets Ther; 2017; 10():5795-5803. PubMed ID: 29263676
[TBL] [Abstract][Full Text] [Related]
16. MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1).
Bai Y; Liao H; Liu T; Zeng X; Xiao F; Luo L; Guo H; Guo L
Eur J Cancer; 2013 Feb; 49(3):710-24. PubMed ID: 22999387
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
18. Pharmacological separation of hEAG and hERG K+ channel function in the human mammary carcinoma cell line MCF-7.
Roy J; Vantol B; Cowley EA; Blay J; Linsdell P
Oncol Rep; 2008 Jun; 19(6):1511-6. PubMed ID: 18497958
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Eag1 K(+) channel in prostate cancer and its significance].
Zheng YQ; Li ZJ; Gao X; Zhang XB; Li FJ; Shi YJ; Luo G; Li W
Zhonghua Nan Ke Xue; 2013 Mar; 19(3):205-9. PubMed ID: 23700723
[TBL] [Abstract][Full Text] [Related]
20. Ether à go-go potassium channel expression in soft tissue sarcoma patients.
Mello de Queiroz F; Suarez-Kurtz G; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():42. PubMed ID: 17022811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
